Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in Japan

Chan, 1998, What causes prostate cancer? A brief summary of the epidemiology, Semin Cancer Biol, 8, 263, 10.1006/scbi.1998.0075 Nakhla, 1996, Stimulation of prostate cancer growth by androgens and estrogens through the intermediacy of sex hormone-binding globulin, Endocrinology, 137, 4126, 10.1210/en.137.10.4126 Andersson, 1993, Serum pituitary and sex steroid hormone levels in the etiology of prostatic cancer—a population-based case–control study, Br J Cancer, 68, 97, 10.1038/bjc.1993.293 1979, Evaluation of plasma hormone concentrations in relation to clinical staging in patients with prostatic cancer, Br J Urol, 51, 382, 10.1111/j.1464-410X.1979.tb02891.x Hoisaeter, 1982, Blood hormone levels related to stages and grades of prostatic cancer, Prostate, 3, 375, 10.1002/pros.2990030407 Imamoto, 2001, Pretreatment serum level of testosterone as a prognostic factor in Japanese men with hormonally treated stage D2 prostate cancer, Endocr J, 48, 573, 10.1507/endocrj.48.573 Massengill, 2003, Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy, J Urol, 169, 1670, 10.1097/01.ju.0000062674.43964.d0 Philip, 2002, No association of serum gonadal or pituitary hormones with prognostic parameters in stages T1 to T3 pNoMo prostate cancer, J Urol, 168, 1188, 10.1016/S0022-5347(05)64623-X 1999, Pretreatment plasma testosterone and estradiol levels in patients with locally advanced or metastasized prostatic cancer, Prostate, 39, 175, 10.1002/(SICI)1097-0045(19990515)39:3<175::AID-PROS5>3.0.CO;2-E Jewett, 1975, The present status of radical prostatectomy for stages A and B prostatic cancer, Urol Clin North Am, 2, 105, 10.1016/S0094-0143(21)01061-2 1980 2001 Tanaka, 1989, Determination of total blood testosterone concentration by coated tube method, and basic examination on specificity of anti-testosterone antibody of the kit, Horumon To Rinsho, 37, 961 Schatzl, 2001, High-grade prostate cancer is associated with low serum testosterone levels, Prostate, 47, 52, 10.1002/pros.1046 Monda, 1995, The correlation between serum prostate-specific antigen and prostate cancer is not influenced by the serum testosterone concentration, Urology, 46, 62, 10.1016/S0090-4295(99)80160-5 Hoffman, 2000, Is low serum free testosterone a marker for high grade prostate cancer?, J Urol, 163, 824, 10.1016/S0022-5347(05)67812-3 Eriksson, 1988, Prognostic value of serum hormone concentrations in prostatic cancer, Prostate, 13, 249, 10.1002/pros.2990130307 Morley, 1997, Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men, Metabolism, 46, 410, 10.1016/S0026-0495(97)90057-3 Harman, 2001, Baltimore longitudinal study of aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men, J Clin Endocrinol Metab, 86, 724, 10.1210/jc.86.2.724 Iwamoto, 2004, Reference ranges of serum total and free testosterone in Japanese male adults, Nippon Hinyokika Gakkai Zasshi, 95, 751 San Francisco, 2006, Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer, J Urol, 175, 1341, 10.1016/S0022-5347(05)00680-4 Eaton, 1999, Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies, Br J Cancer, 80, 930, 10.1038/sj.bjc.6690445 Miller, 1998, Influence of radical prostatectomy on serum hormone levels, J Urol, 160, 449, 10.1016/S0022-5347(01)62922-7 Zhang, 2002, Association between prostate cancer and serum testosterone levels, Prostate, 53, 179, 10.1002/pros.10140 Lukkarinen, 1980, Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma, Scand J Urol Nephrol, 14, 225, 10.3109/00365598009179566 Iguchi, 2002, Endocrine disruptor issues in Japan, Congenit Anom (Kyoto), 42, 106, 10.1111/j.1741-4520.2002.tb00859.x Kuiper, 1997, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α & β, Endocrinology, 138, 863, 10.1210/en.138.3.863 Kuiper, 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β, Endocrinology, 139, 4252, 10.1210/en.139.10.4252 Nishihara, 2000, Estrogenic activities of 517 chemicals by yeast two-hybrid assay, J Health Sci, 46, 282, 10.1248/jhs.46.282 Sohoni, 1998, Several environmental oestrogens are also anti-androgens, J Endocrinol, 158, 327, 10.1677/joe.0.1580327 Tariq, 2005, Andropause: is the emperor wearing any cloths?, Rev Endo Metab Dis, 6, 77, 10.1007/s11154-005-6719-4 Diver, 2006, Analytical and physiological factors affecting the interpretation of serum testosterone concentration in men, Ann Clin Biochem, 43, 3, 10.1258/000456306775141803 Gupta, 2000, Modeling of circadian testosterone in healthy men and hypogonadal men, J Clin Pharmacol, 40, 731, 10.1177/00912700022009486